BlackRock’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$216M Buy
22,650,988
+1,513,197
+7% +$11.8M ﹤0.01% 1627
2025
Q4
$165M Sell
21,137,791
-108,085
-0.5% -$781K ﹤0.01% 1805
2025
Q3
$161M Sell
21,245,876
-179,973
-0.8% -$1.5M ﹤0.01% 1801
2025
Q2
$192M Sell
21,425,849
-1,343,397
-6% -$12.5M ﹤0.01% 1639
2025
Q1
$171M Buy
22,769,246
+674,083
+3% +$5.44M ﹤0.01% 1686
2024
Q4
$166M Buy
22,095,163
+1,179,192
+6% +$8.95M ﹤0.01% 1770
2024
Q3
$159M Buy
20,915,971
+959,716
+5% +$7.3M ﹤0.01% 1794
2024
Q2
$123M Buy
19,956,255
+1,515,526
+8% +$8.36M ﹤0.01% 1905
2024
Q1
$93.7M Sell
18,440,729
-240,641
-1% -$1.35M ﹤0.01% 2093
2023
Q4
$112M Buy
18,681,370
+1,907,066
+11% +$11.1M ﹤0.01% 2005
2023
Q3
$119M Buy
16,774,304
+1,278,601
+8% +$9.19M ﹤0.01% 1892
2023
Q2
$109M Buy
15,495,703
+670,905
+5% +$5.38M ﹤0.01% 1989
2023
Q1
$124M Sell
14,824,798
-94,157
-0.6% -$906K ﹤0.01% 1873
2022
Q4
$171M Buy
14,918,955
+1,143,960
+8% +$14.3M 0.01% 1649
2022
Q3
$174M Sell
13,774,995
-212,423
-2% -$2.73M 0.01% 1580
2022
Q2
$148M Sell
13,987,418
-114,557
-0.8% -$1.18M ﹤0.01% 1754
2022
Q1
$229M Sell
14,101,975
-685,420
-5% -$11M 0.01% 1577
2021
Q4
$205M Sell
14,787,395
-543,463
-4% -$7.19M 0.01% 1720
2021
Q3
$220M Sell
15,330,858
-150,469
-1% -$2.37M 0.01% 1639
2021
Q2
$245M Sell
15,481,327
-760,448
-5% -$10.3M 0.01% 1621
2021
Q1
$165M Sell
16,241,775
-17,970
-0.1% -$185K ﹤0.01% 1852
2020
Q4
$121M Buy
16,259,745
+315,852
+2% +$1.63M ﹤0.01% 1961
2020
Q3
$54.8M Buy
15,943,893
+1,276,979
+9% +$5.47M ﹤0.01% 2238
2020
Q2
$69.9M Buy
14,666,914
+1,271,297
+9% +$5.08M ﹤0.01% 2068
2020
Q1
$26.8M Buy
13,395,617
+1,245,406
+10% +$3.43M ﹤0.01% 2447
2019
Q4
$41.9M Buy
12,150,211
+2,555,431
+27% +$6.43M ﹤0.01% 2475
2019
Q3
$27.5M Buy
9,594,780
+668,889
+7% +$2.08M ﹤0.01% 2633
2019
Q2
$33.8M Buy
8,925,891
+228,525
+3% +$1.38M ﹤0.01% 2551
2019
Q1
$70.8M Sell
8,697,366
-152,061
-2% -$1.3M ﹤0.01% 2085
2018
Q4
$71.4M Buy
8,849,427
+79,571
+0.9% +$619K ﹤0.01% 2023
2018
Q3
$66.9M Buy
8,769,856
+1,013,905
+13% +$6.81M ﹤0.01% 2220
2018
Q2
$44.4M Buy
7,755,951
+281,532
+4% +$1.55M ﹤0.01% 2431
2018
Q1
$35.7M Sell
7,474,419
-139,861
-2% -$719K ﹤0.01% 2462
2017
Q4
$37.4M Buy
7,614,280
+993,100
+15% +$4.81M ﹤0.01% 2450
2017
Q3
$34.7M Buy
6,621,180
+362,803
+6% +$1.86M ﹤0.01% 2495
2017
Q2
$34.8M Buy
6,258,377
+244,100
+4% +$1.49M ﹤0.01% 2463
2017
Q1
$50.5M Buy
6,014,277
+6,004,070
+58,823% +$41.8M ﹤0.01% 2213
2016
Q4
$65K Buy
10,207
+231
+2% +$1.2K ﹤0.01% 2800
2016
Q3
$44K Sell
9,976
-6,699
-40% -$26.8K ﹤0.01% 3022
2016
Q2
$48K Buy
16,675
+11,883
+248% +$36.9K ﹤0.01% 2948
2016
Q1
$14K Buy
4,792
+2,769
+137% +$12.3K ﹤0.01% 3006
2015
Q4
$21K Buy
2,023
+551
+37% +$5.48K ﹤0.01% 2537
2015
Q3
$17K Sell
1,472
-58,800
-98% -$785K ﹤0.01% 2472
2015
Q2
$900K Sell
60,272
-3,345
-5% -$38K ﹤0.01% 1402
2015
Q1
$575K Hold
63,617
﹤0.01% 1500
2014
Q4
$774K Hold
63,617
﹤0.01% 1252
2014
Q3
$622K Sell
63,617
-4,300
-6% -$52.7K ﹤0.01% 1309
2014
Q2
$866K Buy
67,917
+67,903
+485,021% +$661K ﹤0.01% 1232
2014
Q1
$0 Buy
+14
New +$149 ﹤0.01% 3125

Other funds holding BCRX